{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T14:12:56Z","timestamp":1771423976996,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"DOI":"10.1186\/s13058-026-02227-6","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T07:36:39Z","timestamp":1769499399000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Toxicity profiles of proton and photon radiotherapy in postoperative breast cancer: a 10-year real-world cohort study"],"prefix":"10.1186","volume":"28","author":[{"given":"Chi-Chang","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Chuan","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Ting","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Hui","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Cheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miao-Fen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"issue":"9804","key":"2227_CR1","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1016\/S0140-6736(11)61629-2","volume":"378","author":"S Darby","year":"2011","unstructured":"Darby S, McGale P, Early Breast Cancer Trialists\u2019 Collaborative Group, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011;378(9804):1707\u201316. https:\/\/doi.org\/10.1016\/S0140-6736(11)61629-2.","journal-title":"Lancet"},{"issue":"9935","key":"2227_CR2","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1016\/S0140-6736(14)60488-8","volume":"383","author":"Ebctcg","year":"2014","unstructured":"Ebctcg, McGale P, Taylor C, et al. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet. 2014;383(9935):2127\u201335. https:\/\/doi.org\/10.1016\/S0140-6736(14)60488-8.","journal-title":"Lancet"},{"issue":"3","key":"2227_CR3","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.ijrobp.2006.12.016","volume":"68","author":"Z Kahan","year":"2007","unstructured":"Kahan Z, Csenki M, Varga Z, et al. The risk of early and late lung sequelae after conformal radiotherapy in breast cancer patients. Int J Radiat Oncol Biol Phys. 2007;68(3):673\u201381. https:\/\/doi.org\/10.1016\/j.ijrobp.2006.12.016.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"2227_CR4","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s10549-014-3016-5","volume":"146","author":"C Omarini","year":"2014","unstructured":"Omarini C, Thanopoulou E, Johnston SR. Pneumonitis and pulmonary fibrosis associated with breast cancer treatments. Breast Cancer Res Treat. 2014;146(2):245\u201358. https:\/\/doi.org\/10.1007\/s10549-014-3016-5.","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"2227_CR5","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.radonc.2012.02.008","volume":"103","author":"A Sardaro","year":"2012","unstructured":"Sardaro A, Petruzzelli MF, D\u2019Errico MP, Grimaldi L, Pili G, Portaluri M. Radiation-induced cardiac damage in early left breast cancer patients: risk factors, biological mechanisms, radiobiology, and dosimetric constraints. Radiother Oncol. 2012;103(2):133\u201342. https:\/\/doi.org\/10.1016\/j.radonc.2012.02.008.","journal-title":"Radiother Oncol"},{"issue":"11","key":"2227_CR6","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa1209825","volume":"368","author":"SC Darby","year":"2013","unstructured":"Darby SC, Ewertz M, McGale P, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013;368(11):987\u201398. https:\/\/doi.org\/10.1056\/NEJMoa1209825.","journal-title":"N Engl J Med"},{"issue":"3","key":"2227_CR7","doi-asserted-by":"publisher","first-page":"e79","DOI":"10.1016\/j.prro.2017.07.005","volume":"8","author":"JC Hong","year":"2018","unstructured":"Hong JC, Rahimy E, Gross CP, et al. Radiation dose and cardiac risk in breast cancer treatment: an analysis of modern radiation therapy including community settings. Pract Radiat Oncol. 2018;8(3):e79\u201386. https:\/\/doi.org\/10.1016\/j.prro.2017.07.005.","journal-title":"Pract Radiat Oncol"},{"issue":"30","key":"2227_CR8","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1111\/1759-7714.15451","volume":"15","author":"K Qiao","year":"2024","unstructured":"Qiao K, Wei Y, Tao C, Zhu J, Yuan S. Proton therapy for breast cancer: reducing toxicity. Thorac Cancer. 2024;15(30):2156\u201365. https:\/\/doi.org\/10.1111\/1759-7714.15451.","journal-title":"Thorac Cancer"},{"issue":"15","key":"2227_CR9","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1200\/JCO.2016.72.0722","volume":"35","author":"C Taylor","year":"2017","unstructured":"Taylor C, Correa C, Duane FK, et al. Estimating the risks of breast cancer radiotherapy: evidence from modern radiation doses to the lungs and heart and from previous randomized trials. J Clin Oncol. 2017;35(15):1641\u20139. https:\/\/doi.org\/10.1200\/JCO.2016.72.0722.","journal-title":"J Clin Oncol"},{"key":"2227_CR10","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.radonc.2020.05.035","volume":"149","author":"H Paganetti","year":"2020","unstructured":"Paganetti H, Depauw N, Johnson A, Forman RB, Lau J, Jimenez R. The risk for developing a secondary cancer after breast radiation therapy: comparison of photon and proton techniques. Radiother Oncol. 2020;149:212\u20138. https:\/\/doi.org\/10.1016\/j.radonc.2020.05.035.","journal-title":"Radiother Oncol"},{"issue":"2","key":"2227_CR11","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ijrobp.2021.05.110","volume":"111","author":"RW Mutter","year":"2021","unstructured":"Mutter RW, Choi JI, Jimenez RB, et al. Proton therapy for breast cancer: a consensus statement from the particle therapy cooperative group breast cancer subcommittee. Int J Radiat Oncol Biol Phys. 2021;111(2):337\u201359. https:\/\/doi.org\/10.1016\/j.ijrobp.2021.05.110.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"2227_CR12","first-page":"4783","volume":"13","author":"CC Hsieh","year":"2023","unstructured":"Hsieh CC, Yu CC, Chu CH, Chen WC, Chen MF. Radiation-induced skin and heart toxicity in patients with breast cancer treated with adjuvant proton radiotherapy: a comparison with photon radiotherapy. Am J Cancer Res. 2023;13(10):4783\u201393.","journal-title":"Am J Cancer Res"},{"key":"2227_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-10-508","volume":"23","author":"MF Chen","year":"2010","unstructured":"Chen MF, Chen WC, Lai CH, Hung CH, Liu KC, Cheng YH. Predictive factors of radiation-induced skin toxicity in breast cancer patients. BMC Cancer. 2010;23:508. https:\/\/doi.org\/10.1186\/1471-2407-10-508.","journal-title":"BMC Cancer"},{"key":"2227_CR14","doi-asserted-by":"publisher","first-page":"9173","DOI":"10.2147\/CMAR.S269893","volume":"12","author":"CH Chen","year":"2020","unstructured":"Chen CH, Hsieh CC, Chang CS, Chen MF. A retrospective analysis of dose distribution and toxicity in patients with left breast cancer treated with adjuvant intensity-modulated radiotherapy: comparison with three-dimensional conformal radiotherapy. Cancer Manag Res. 2020;12:9173\u201382. https:\/\/doi.org\/10.2147\/CMAR.S269893.","journal-title":"Cancer Manag Res"},{"issue":"3","key":"2227_CR15","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.ijrobp.2013.01.038","volume":"86","author":"SM MacDonald","year":"2013","unstructured":"MacDonald SM, Patel SA, Hickey S, et al. Proton therapy for breast cancer after mastectomy: early outcomes of a prospective clinical trial. Int J Radiat Oncol Biol Phys. 2013;86(3):484\u201390.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"2227_CR16","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.ijrobp.2015.09.018","volume":"95","author":"JA Bradley","year":"2016","unstructured":"Bradley JA, Dagan R, Ho MW, et al. Initial report of a prospective dosimetric and clinical feasibility trial demonstrates the potential of protons to increase the therapeutic ratio in breast cancer compared With photons. Int J Radiat Oncol Biol Phys. 2016;95(1):411\u201321.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"2227_CR17","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.ijrobp.2023.05.036","volume":"117","author":"RW Gao","year":"2023","unstructured":"Gao RW, Mullikin TC, Aziz KA, et al. Postmastectomy intensity modulated proton therapy: 5-year oncologic and patient-reported outcomes. Int J Radiat Oncol Biol Phys. 2023;117(4):846\u201356. https:\/\/doi.org\/10.1016\/j.ijrobp.2023.05.036.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2227_CR18","doi-asserted-by":"publisher","DOI":"10.1177\/15330338241234788","volume":"23","author":"XY Wu","year":"2024","unstructured":"Wu XY, Chen M, Cao L, Li M, Chen JY. Proton therapy in breast cancer: a review of potential approaches for patient selection. Technol Cancer Res Treat. 2024;23:15330338241234788. https:\/\/doi.org\/10.1177\/15330338241234788.","journal-title":"Technol Cancer Res Treat"},{"issue":"2","key":"2227_CR19","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.semradonc.2017.11.009","volume":"28","author":"LZ Braunstein","year":"2018","unstructured":"Braunstein LZ, Cahlon O. Potential morbidity reduction with proton radiation therapy for breast cancer. Semin Radiat Oncol. 2018;28(2):138\u201349. https:\/\/doi.org\/10.1016\/j.semradonc.2017.11.009.","journal-title":"Semin Radiat Oncol"},{"key":"2227_CR20","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ctrv.2015.12.007","volume":"43","author":"J Doyen","year":"2016","unstructured":"Doyen J, Falk AT, Floquet V, Herault J, Hannoun-Levi JM. Proton beams in cancer treatments: clinical outcomes and dosimetric comparisons with photon therapy. Cancer Treat Rev. 2016;43:104\u201312. https:\/\/doi.org\/10.1016\/j.ctrv.2015.12.007.","journal-title":"Cancer Treat Rev"},{"key":"2227_CR21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ctrv.2017.11.006","volume":"63","author":"E Kammerer","year":"2018","unstructured":"Kammerer E, Guevelou JL, Chaikh A, et al. Proton therapy for locally advanced breast cancer: a systematic review of the literature. Cancer Treat Rev. 2018;63:19\u201327. https:\/\/doi.org\/10.1016\/j.ctrv.2017.11.006.","journal-title":"Cancer Treat Rev"},{"issue":"3","key":"2227_CR22","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1053\/srao.2001.23483","volume":"11","author":"G Gagliardi","year":"2001","unstructured":"Gagliardi G, Lax I, Rutqvist LE. Partial irradiation of the heart. Semin Radiat Oncol. 2001;11(3):224\u201333. https:\/\/doi.org\/10.1053\/srao.2001.23483.","journal-title":"Semin Radiat Oncol"},{"key":"2227_CR23","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ctrv.2018.03.008","volume":"68","author":"Q Zhu","year":"2018","unstructured":"Zhu Q, Kirova YM, Cao L, Arsene-Henry A, Chen J. Cardiotoxicity associated with radiotherapy in breast cancer: a question-based review with current literatures. Cancer Treat Rev. 2018;68:9\u201315. https:\/\/doi.org\/10.1016\/j.ctrv.2018.03.008.","journal-title":"Cancer Treat Rev"},{"issue":"3 Suppl","key":"2227_CR24","doi-asserted-by":"publisher","first-page":"S77","DOI":"10.1016\/j.ijrobp.2009.04.093","volume":"76","author":"G Gagliardi","year":"2010","unstructured":"Gagliardi G, Constine LS, Moiseenko V, et al. Radiation dose-volume effects in the heart. Int J Radiat Oncol Biol Phys. 2010;76(3 Suppl):S77-85. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.04.093.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"2227_CR25","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s10549-014-3149-6","volume":"148","author":"ME Mast","year":"2014","unstructured":"Mast ME, Vredeveld EJ, Credoe HM, et al. Whole breast proton irradiation for maximal reduction of heart dose in breast cancer patients. Breast Cancer Res Treat. 2014;148(1):33\u20139. https:\/\/doi.org\/10.1007\/s10549-014-3149-6.","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"2227_CR26","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.radonc.2013.03.028","volume":"107","author":"RB Jimenez","year":"2013","unstructured":"Jimenez RB, Goma C, Nyamwanda J, et al. Intensity modulated proton therapy for postmastectomy radiation of bilateral implant reconstructed breasts: a treatment planning study. Radiother Oncol. 2013;107(2):213\u20137. https:\/\/doi.org\/10.1016\/j.radonc.2013.03.028.","journal-title":"Radiother Oncol"},{"issue":"3","key":"2227_CR27","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.ijrobp.2009.02.062","volume":"76","author":"C Ares","year":"2010","unstructured":"Ares C, Khan S, Macartain AM, et al. Postoperative proton radiotherapy for localized and locoregional breast cancer: potential for clinically relevant improvements? Int J Radiat Oncol Biol Phys. 2010;76(3):685\u201397. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.02.062.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2227_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13215426","author":"GC Semeraro","year":"2021","unstructured":"Semeraro GC, Cipolla CM, Cardinale DM. Role of cardiac biomarkers in cancer patients. Cancers (Basel). 2021. https:\/\/doi.org\/10.3390\/cancers13215426.","journal-title":"Cancers (Basel)"},{"key":"2227_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20163874","author":"M Forte","year":"2019","unstructured":"Forte M, Madonna M, Schiavon S, Valenti V, Versaci F, Zoccai GB, et al. Cardiovascular pleiotropic effects of natriuretic peptides. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20163874.","journal-title":"Int J Mol Sci"},{"key":"2227_CR30","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1080\/0284186X.2019.1630751","volume":"58","author":"T Skytta","year":"2019","unstructured":"Skytta T, Tuohinen S, Luukkaala T, Virtanen V, Raatikainen P, Kellokumpu-Lehtinen PL. Adjuvant radiotherapy-induced cardiac changes among patients with early breast cancer: a three-year follow-up study. Acta Oncol. 2019;58:1250\u20138.","journal-title":"Acta Oncol"},{"issue":"3","key":"2227_CR31","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S1053-4296(03)00034-1","volume":"13","author":"LB Marks","year":"2003","unstructured":"Marks LB, Yu X, Vujaskovic Z, Small W Jr., Folz R, Anscher MS. Radiation-induced lung injury. Semin Radiat Oncol. 2003;13(3):333\u201345. https:\/\/doi.org\/10.1016\/S1053-4296(03)00034-1.","journal-title":"Semin Radiat Oncol"},{"issue":"23","key":"2227_CR32","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1093\/jnci\/93.23.1806","volume":"93","author":"AG Taghian","year":"2001","unstructured":"Taghian AG, Assaad SI, Niemierko A, et al. Risk of pneumonitis in breast cancer patients treated with radiation therapy and combination chemotherapy with paclitaxel. J Natl Cancer Inst. 2001;93(23):1806\u201311. https:\/\/doi.org\/10.1093\/jnci\/93.23.1806.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"2227_CR33","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/s0360-3016(01)01715-1","volume":"52","author":"PA Lind","year":"2002","unstructured":"Lind PA, Marks LB, Hardenbergh PH, et al. Technical factors associated with radiation pneumonitis after local +\/- regional radiation therapy for breast cancer. Int J Radiat Oncol Biol Phys. 2002;52(1):137\u201343. https:\/\/doi.org\/10.1016\/s0360-3016(01)01715-1.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"2227_CR34","doi-asserted-by":"publisher","first-page":"S70","DOI":"10.1016\/j.ijrobp.2009.06.091","volume":"76","author":"LB Marks","year":"2010","unstructured":"Marks LB, Bentzen SM, Deasy JO, et al. Radiation dose-volume effects in the lung. Int J Radiat Oncol Biol Phys. 2010;76(3):S70\u20136. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.06.091.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"2227_CR35","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ijrobp.2009.04.019","volume":"77","author":"R Mazeron","year":"2010","unstructured":"Mazeron R, Etienne-Mastroianni B, Perol D, et al. Predictive factors of late radiation fibrosis: a prospective study in non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2010;77(1):38\u201343. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.04.019.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"2227_CR36","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ijrobp.2009.02.005","volume":"76","author":"J Zhang","year":"2010","unstructured":"Zhang J, Ma J, Zhou S, et al. Radiation-induced reductions in regional lung perfusion: 0.1-12 year data from a prospective clinical study. Int J Radiat Oncol Biol Phys. 2010;76(2):425\u201332.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"2227_CR37","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0360-3016(01)01619-4","volume":"51","author":"M Fan","year":"2001","unstructured":"Fan M, Marks LB, Lind P, et al. Relating radiation-induced regional lung injury to changes in pulmonary function tests. Int J Radiat Oncol Biol Phys. 2001;51(2):311\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"23","key":"2227_CR38","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1093\/jnci\/93.23.1806","volume":"93","author":"AG Taghian","year":"2001","unstructured":"Taghian AG, Jeong J-H, Li JJ, DeLeo AB, Abi-Raad R. Risk of pneumonitis in breast cancer patients treated with radiotherapy and adjuvant paclitaxel. J Natl Cancer Inst. 2001;93(23):1806\u201314.","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"2227_CR39","doi-asserted-by":"publisher","first-page":"6355","DOI":"10.21873\/anticanres.13847","volume":"39","author":"EM Werner","year":"2019","unstructured":"Werner EM, Eggert MC, Bohnet S, Rades D. Prevalence and characteristics of pneumonitis following irradiation of breast cancer. Anticancer Res. 2019;39(11):6355\u20138.","journal-title":"Anticancer Res"},{"issue":"11","key":"2227_CR40","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/S1470-2045(13)70386-3","volume":"14","author":"JS Haviland","year":"2013","unstructured":"Haviland JS, Owen JR, Dewar JA, START Trialists\u2019 Group, et al. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. Lancet Oncol. 2013;14(11):1086\u201394.","journal-title":"Lancet Oncol"},{"issue":"1","key":"2227_CR41","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.radonc.2013.01.002","volume":"106","author":"T Grantzau","year":"2013","unstructured":"Grantzau T, Mellemkjaer L, Overgaard J. Second primary cancers after adjuvant radiotherapy in early breast cancer patients: a national population based study under the Danish Breast Cancer Cooperative Group (DBCG). Radiother Oncol. 2013;106(1):42\u20139. https:\/\/doi.org\/10.1016\/j.radonc.2013.01.002.","journal-title":"Radiother Oncol"},{"issue":"3","key":"2227_CR42","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1080\/0284186X.2020.1862421","volume":"60","author":"AMC Santos","year":"2021","unstructured":"Santos AMC, Kotsanis A, Cunningham L, Penfold SN. Estimating the second primary cancer risk due to proton therapy compared to hybrid IMRT for left sided breast cancer. Acta Oncol. 2021;60(3):300\u20134. https:\/\/doi.org\/10.1080\/0284186X.2020.1862421.","journal-title":"Acta Oncol"},{"issue":"2","key":"2227_CR43","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.ijrobp.2015.01.005","volume":"92","author":"JJ Cuaron","year":"2015","unstructured":"Cuaron JJ, Chon B, Tsai H, et al. Early toxicity in patients treated with postoperative proton therapy for locally advanced breast cancer. Int J Radiat Oncol Biol Phys. 2015;92(2):284\u201391. https:\/\/doi.org\/10.1016\/j.ijrobp.2015.01.005.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2227_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-018-1004-3","author":"X Liang","year":"2018","unstructured":"Liang X, Bradley JA, Zheng D, et al. Prognostic factors of radiation dermatitis following passive-scattering proton therapy for breast cancer. Radiat Oncol. 2018. https:\/\/doi.org\/10.1186\/s13014-018-1004-3.","journal-title":"Radiat Oncol"},{"issue":"6","key":"2227_CR45","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1080\/0284186X.2019.1591638","volume":"58","author":"F Fellin","year":"2019","unstructured":"Fellin F, Iacco M, D\u2019Avino V, et al. Potential skin morbidity reduction with intensity-modulated proton therapy for breast cancer with nodal involvement. Acta Oncol. 2019;58(6):934\u201342.","journal-title":"Acta Oncol"},{"issue":"13","key":"2227_CR46","doi-asserted-by":"publisher","first-page":"1067500","DOI":"10.3389\/fonc.2023.1067500","volume":"20","author":"M Sayan","year":"2023","unstructured":"Sayan M, Hathout L, Kilic SS, et al. Reconstructive complications and early toxicity in breast cancer patients treated with proton-based postmastectomy radiation therapy. Front Oncol. 2023;20(13):1067500.","journal-title":"Front Oncol"},{"issue":"9618","key":"2227_CR47","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/S0140-6736(08)60348-7","volume":"371","author":"SM Bentzen","year":"2008","unstructured":"Bentzen SM, Agrawal RK, Aird EG, START Trialists\u2019 Group, et al. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet. 2008;371(9618):1098\u2013107.","journal-title":"Lancet"},{"issue":"6","key":"2227_CR48","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1056\/NEJMoa0906260","volume":"362","author":"TJ Whelan","year":"2010","unstructured":"Whelan TJ, Pignol JP, Levine MN, et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med. 2010;362(6):513\u201320.","journal-title":"N Engl J Med"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-026-02227-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02227-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02227-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T13:40:33Z","timestamp":1771422033000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13058-026-02227-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2227"],"URL":"https:\/\/doi.org\/10.1186\/s13058-026-02227-6","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"assertion":[{"value":"26 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the institutional review board of Chang Gung Memorial hospital (IRB No. 202100807B0 and 202400956B0). Informed consent forms were signed by the enrolled patients prior to their participation in the prospective study (IRB No. 202100807B0). This retrospective study (IRB No. 202400956B0) was approved, and a waiver of informed consent was obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"49"}}